Industry partners

What are the benefits of FinnGen and Finland for our industry partners? This autumn we took the opportunity to interview some representatives of our pharmaceutical partners who wanted to share their experiences of FinnGen.
FinnGen: an exciting academic-industrial collaboration enabling genetic discoveries

Access to FinnGen’s unique combination of longitudinal phenotypic and genome data has attracted researchers from the pharmaceutical industry and several international companies have decided to partner with us. 

Watch these short interviews to hear why!


Heiko Runz, Biogen


Caroline Fox, Merck

Mark McCarthy, Genentech


Meg Ehm, GSK